GEOFF SZABO: Open Payments
NPI 1629482310 · BRISTOL, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,651 in 151 payments from 21 companies in 2025. Trend: 2023 $3,716 · 2024 $3,747 · 2025 $3,651
Food & beverage: $3,651
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 27 | $737 |
| GlaxoSmithKline, LLC. | 30 | $540 |
| Regeneron Healthcare Solutions, Inc. | 20 | $531 |
| United Therapeutics Corporation | 6 | $256 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $209 |
| Insmed, Inc. | 8 | $185 |
| Verona Pharma, Inc. | 10 | $183 |
| Viatris Specialty LLC | 9 | $182 |
| Baxter Healthcare | 6 | $174 |
| Grifols USA, LLC | 6 | $156 |
Products named: DUPIXENT, NUCALA, TEZSPIRE, BREZTRI, TRELEGY ELLIPTA, Arikayce, Ohtuvayre, YUPELRI.
Industry payments across TN — which companies pay providers there.
